Navistar RMT Thermocool is back
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/Biosense Webster's magnetic irrigated catheter is re-approved for sale in the U.S., after a manufacturing problem delayed its U.S. debut. The device, manufactured by Johnson & Johnson/Biosense Webster and intended for use with Stereotaxis' Niobe magnetic ablation steering system, was initially OK'd in January 2008, but was pulled after the two firms identified char or coagulation forming in some catheters during the manufacturing process (1"The Gray Sheet" Aug. 11, 2008, p. 18). Stereotaxis is counting on the RMT catheter, which was relaunched in Europe last winter, to drive sales of Niobe. Unlike J&J's manual Navistar Thermocool and EZ Steer catheters, the RMT catheters are not yet approved to treat atrial fibrillation
You may also be interested in...
Earnings Roundup: Updates From Quarterly Business Reports
With earnings season in full swing, device firms are disclosing financial results and, in some cases, more details about their future plans. Here are highlights from earnings reports released during the past week
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.